[3] One-Two Combo Packs a Punch in High-Risk CLL. Retrieved May 29, 2019, from https://www.medpagetoday.com/hematologyoncology/leukemia/80127
原标题
NEJM:完全缓解率88%!慢性淋巴细胞白血病一线组合疗法效果喜人
[3] One-Two Combo Packs a Punch in High-Risk CLL. Retrieved May 29, 2019, from https://www.medpagetoday.com/hematologyoncology/leukemia/80127
原标题
NEJM:完全缓解率88%!慢性淋巴细胞白血病一线组合疗法效果喜人
小编推荐:
安进慢性心衰药omecamtiv
疫情期间常见病、慢性病
安进慢性心衰药omecamtiv
疫情期间常见病、慢性病